Name:TMEM65ex3genoFor Sequence:TGC CAG CAT AAC TCC TGT CA Product:25 nmole DNA Oligo… and 1 more item

The University of Virginia awarded contract A207_PO-0452087-V3 to Integrated DNA Technologies Inc on August 1, 2026, with a cumulative contract value of nine dollars. The contract is for the procurement of synthetic DNA oligonucleotides, specifically two distinct sequences designated for genomic applications. The first line item comprises four units of TMEM65ex3genoFor, a 25 nanomole DNA oligonucleotide with a 20-base sequence (TGC CAG CAT AAC TCC TGT CA) prepared through standard desalting purification. The second line item consists of five units of TMEM65ex3genoRev, a 25 nanomole DNA oligonucleotide with a 26-base sequence (GGA AAA TGT AGA GCA CAC TAA TTT CT) also processed via standard desalting purification.

Both line items are priced at one dollar per unit and are designated for delivery to the buyer. The oligonucleotides appear to be complementary forward and reverse sequences intended for molecular biology applications, likely supporting research or diagnostic activities at the University of Virginia. The minimal contract value and specific nomenclature suggest this represents a purchase order for research-grade molecular reagents rather than a substantial procurement engagement.